90 related articles for article (PubMed ID: 19349130)
41. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia.
Holtmann G; Gschossmann J; Karaus M; Fischer T; Becker B; Mayr P; Gerken G
Aliment Pharmacol Ther; 1999 Nov; 13(11):1459-65. PubMed ID: 10571602
[TBL] [Abstract][Full Text] [Related]
42. The role of liquid simethicone in enhancing endoscopic visibility prior to esophagogastroduodenoscopy (EGD): A prospective, randomized, double-blinded, placebo-controlled trial.
Keeratichananont S; Sobhonslidsuk A; Kitiyakara T; Achalanan N; Soonthornpun S
J Med Assoc Thai; 2010 Aug; 93(8):892-7. PubMed ID: 20718163
[TBL] [Abstract][Full Text] [Related]
43. Effect of magnesium alginate plus simethicone on gastroesophageal reflux in infants.
Ummarino D; Miele E; Martinelli M; Scarpato E; Crocetto F; Sciorio E; Staiano A
J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):230-5. PubMed ID: 25079477
[TBL] [Abstract][Full Text] [Related]
44. Activated charcoal, simethicone, and intestinal gas: a double-blind study.
Jain NK; Patel VP; Pitchumoni S
Ann Intern Med; 1986 Jul; 105(1):61-2. PubMed ID: 3717809
[No Abstract] [Full Text] [Related]
45. Efficacy of antibiotherapy for treating flatus incontinence associated with small intestinal bacterial overgrowth: A pilot randomized trial.
Melchior C; Gourcerol G; Bridoux V; Ducrotté P; Quinton JF; Leroi AM
PLoS One; 2017; 12(8):e0180835. PubMed ID: 28763464
[TBL] [Abstract][Full Text] [Related]
46. Effect of simethicone on lactulose-induced H2 production and gastrointestinal symptoms.
Friis H; Bodé S; Rumessen JJ; Gudmand-Høyer E
Digestion; 1991; 49(4):227-30. PubMed ID: 1797602
[TBL] [Abstract][Full Text] [Related]
47. Efficacy of
Sawangroj N; Budkaew J; Chumworathayi B
F1000Res; 2019; 8():1827. PubMed ID: 33510892
[No Abstract] [Full Text] [Related]
48. Fluctuation in dyspepsia subgroups over time. A three-year follow-up of patients consulting general practice for dyspepsia.
Meineche-Schmidt V; Jørgensen T
Dig Liver Dis; 2002 May; 34(5):332-8. PubMed ID: 12118950
[TBL] [Abstract][Full Text] [Related]
49. The value of simethicone in abdominal preparation.
Suoranta H; Standertskjöld-Nordenstam CG; Lähde S
Radiology; 1979 Nov; 133(2):307-8. PubMed ID: 493514
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study.
Burta O; Iacobescu C; Mateescu RB; Nicolaie T; Tiuca N; Pop CS
Transl Gastroenterol Hepatol; 2018; 3():72. PubMed ID: 30511026
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of activated charcoal-sorbitol suspension as an antidote.
Picchioni AL; Chin L; Gillespie T
J Toxicol Clin Toxicol; 1982 Jul; 19(5):433-44. PubMed ID: 7175988
[TBL] [Abstract][Full Text] [Related]
52. The effect of clebopride-simethicone combination therapy on echographic visualization of retrogastric organs.
Herrerías Gutiérrez JM; García Montes J
Clin Ther; 1994; 16(3):483-9. PubMed ID: 7923315
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.
Petrisor DC; Etropolska Z; Elenski K; Dimitrova E; Santos J
Dig Dis Sci; 2024 Jan; 69(1):161-168. PubMed ID: 37923826
[TBL] [Abstract][Full Text] [Related]
54. Mucolytic-antifoam solution for reduction of artifacts during endoscopic ultrasonography: a randomized controlled trial.
Yiengpruksawan A; Lightdale CJ; Gerdes H; Botet JF
Gastrointest Endosc; 1991; 37(5):543-6. PubMed ID: 1657680
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of small-volume simethicone given at least 30 min before gastroscopy.
Song M; Kwek AB; Law NM; Ong JP; Tan JY; Harichander Thurairajah P; Ang DS; Ang TL
World J Gastrointest Pharmacol Ther; 2016 Nov; 7(4):572-578. PubMed ID: 27867691
[TBL] [Abstract][Full Text] [Related]
56. Use of simethicone as a patient preparation for abdominal sonography.
Sommer G; Filly RA; Laing FC
Radiology; 1977 Oct; 125(1):219-21. PubMed ID: 897173
[TBL] [Abstract][Full Text] [Related]
57. Simethicone for adults at long last.
Graham JR
Med J Aust; 1988 Jan; 148(1):56. PubMed ID: 3336311
[No Abstract] [Full Text] [Related]
58. Treatment of Excessive Intestinal Gas.
Azpiroz F; Serra J
Curr Treat Options Gastroenterol; 2004 Aug; 7(4):299-305. PubMed ID: 15238205
[TBL] [Abstract][Full Text] [Related]
59. Correction: Efficacy and Safety of Pea Protein and Xyloglucan Versus Simethicone in Functional Abdominal Bloating and Distension.
Petrisor DC; Etropolska Z; Elenski K; Dimitrova E; Santos J
Dig Dis Sci; 2024 May; 69(5):1897-1899. PubMed ID: 38564150
[No Abstract] [Full Text] [Related]
60. Efficacy of a simethicone, activated charcoal and magnesium oxide combination (Carbosymag®) in functional dyspepsia: results of a general practice-based randomized trial.
Coffin B; Bortolloti C; Bourgeois O; Denicourt L
Clin Res Hepatol Gastroenterol; 2011 Jun; 35(6-7):494-9. PubMed ID: 21478070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
